Documented clinical and veterinary cases demonstrating the therapeutic outcomes of F LAZAR technology across human medical and animal applications.
Documented outcomes from F LAZAR treatment in ophthalmology, burn recovery, and physiotherapy.
A pilot clinical study was conducted to evaluate the effect of low-level laser therapy on visual function in glaucomatous patients. The study used F LAZAR technology applied to patients with established glaucoma and measured outcomes through standardized visual field assessments.
Key Findings:
A patient presented with severe second and third degree burns on the palm and fingers. The presentation included large blisters and necrotic areas, dry and thickened skin, high risk of hypertrophic scarring, and potential for permanent hand deformation and loss of flexibility.
F LAZAR treatment was initiated and maintained over two weeks. The technology worked at the cellular level to redirect the body's healing response — stimulating fibroblast activity, reducing inflammatory cytokines, and supporting organized tissue regeneration.
Outcomes After 2 Weeks:
A competitive jockey sustained a fracture to the arm involving the elbow joint — an injury that typically requires extended recovery and is known to compromise joint mobility and performance. The athlete needed to return to professional racing as quickly as possible.
F LAZAR treatment was applied to support accelerated bone consolidation, reduce inflammation around the elbow joint, and restore mobility. The photonic stimulation promoted cellular repair at the fracture site and supported surrounding soft tissue recovery.
Outcomes:
Documented outcomes from F LAZAR treatment in equine, canine, and camelid veterinary care.
Horse "Stormy" presented at Al-Jiyad Stables with multiple concurrent conditions: active laminitis causing slow and painful walking, visible skin lacerations on the face, and general signs of physical discomfort. The combination of conditions required multi-target treatment.
F LAZAR treatment was initiated in December 2024. Four treatment sessions were administered, targeting the laminitis inflammation, wound sites, and overall systemic support.
Outcomes After 4 Sessions:
Two racehorses presented with knee joint pain on front legs, low metabolism, elevated heart rate, and skin lacerations. Treatment commenced just 4 days before a scheduled competition in January 2025, requiring rapid and effective results.
F LAZAR treatment was applied in four intensive sessions targeting the joint inflammation, metabolic support, and wound healing. The short treatment window made the outcomes particularly significant.
Outcomes:
A pony presented with behavioral problems including biting, erratic and aggressive behavior, elevated stress levels, and skin lacerations. The behavioral issues were linked to chronic stress, which was compounding the physical wounds and affecting daily handling and care.
F LAZAR treatment was applied across four sessions, with the therapy targeting cortisol reduction, neurological calming, and wound site support. Outcomes were measured across both behavioral and physical markers.
Outcomes After 4 Sessions:
Dogs presented with corneal opacity and corneal injury at a veterinary clinic. Conventional treatment for corneal damage in dogs is limited and often involves long healing periods with uncertain outcomes. F LAZAR was applied as a supportive therapy targeting the corneal tissue repair and local inflammation.
Applications and Outcomes:
Camels in the UAE are traditionally treated for muscle pain and skin injuries using branding — a method that leaves permanent scarring, reduces skin quality, and lowers the animal's market value. F LAZAR was applied as a direct alternative to achieve the same therapeutic outcomes without the damaging side effects.
Treatment targeted existing wound sites, old scar tissue, and areas of chronic inflammation. The photonic energy stimulated regenerative processes at the tissue level while supporting systemic immune function.
Outcomes:
